Detection of global hypermethylation in well-differentiated thyroid neoplasms by immunohistochemical (5-methylcytidine) analysis

Journal of Endocrinological Investigation
S KeelawatApiwat Mutirangura

Abstract

While global hypomethylation of DNA has been found in several malignancies, studies on thyroid tumours have shown controversial results using different techniques. To help resolve this issue, we assessed methylation status using two different techniques in papillary thyroid carcinomas (PTC) and follicular adenomas (FA) and carcinomas (FTC), comparing adjacent non-neoplastic thyroid tissue. A series of 15 FA, 18 FTC and 17 PTC were assessed by: (1) measurement of methylation levels of long interspersed nuclear elements (LINE-1) using a combined bisulfite restriction analysis polymerase chain reaction protocol and (2) immunostaining with an anti-5-methylcytidine antibody that detects methylated DNA regardless of the DNA sequence. Immunostaining was scored by image analysis. Methylation levels of LINE-1 in FA, FTC and PTC were not significantly different from adjacent normal tissue. There was no significant difference in methylation levels of LINE-1 between FA, FTC and PTC (p = 0.44). By immunohistochemical staining for methylation, the 5-methylcytidine score was significantly higher in tumours than in normal tissue counterparts, for FA (p < 0.001), FTC (p = 0.04) and PTC (p = 0.02). PTC showed the highest 5-methylcytidine express...Continue Reading

References

Jul 10, 1992·Cell·A Bird
Sep 10, 1984·Biochimica Et Biophysica Acta·A Razin, M Szyf
Aug 3, 2002·Oncogene·Melanie Ehrlich
Aug 31, 2002·Genes, Chromosomes & Cancer·Wolfgang A SchulzTapio Visakorpi
May 14, 2005·Virchows Archiv : an International Journal of Pathology·Bogdan GaluscaMichel Peoc'h
Sep 13, 2005·Head & Neck·Chandrika J PiyathilakeWilliam E Grizzle
Jun 16, 2006·Cancer Biology & Therapy·Anne NeuhausenWolfgang A Schulz
Sep 2, 2006·Endocrinology·Mingzhao Xing
Oct 19, 2006·Biochimica Et Biophysica Acta·Ann S WilsonPeter L Molloy
Jun 22, 2007·International Journal of Cancer. Journal International Du Cancer·Ian M SmithJoseph A Califano
May 14, 2009·International Journal of Cancer. Journal International Du Cancer·Si Ho ChoiAllen S Yang
Feb 18, 2011·Journal of Molecular Endocrinology·Diego RussoSebastiano Filetti
Feb 14, 2012·Clinica Chimica Acta; International Journal of Clinical Chemistry·Nakarin KitkumthornApiwat Mutirangura
May 15, 2013·The Journal of Clinical Endocrinology and Metabolism·Sandra Rodríguez-RoderoMario F Fraga
May 18, 2013·European Journal of Haematology·Antonella PoloniPietro Leoni
Jan 3, 2014·International Journal of Cancer. Journal International Du Cancer·Veronika MancikovaMercedes Robledo
Jan 16, 2014·The Journal of Clinical Endocrinology and Metabolism·Ryan J EllisElectron Kebebew
Nov 25, 2014·Cell·UNKNOWN Cancer Genome Atlas Research Network

❮ Previous
Next ❯

Citations

Nov 23, 2017·The Journal of Clinical Endocrinology and Metabolism·Esther N Klein HesselinkMireia Jordà
May 12, 2020·Cancer Biomarkers : Section a of Disease Markers·Iulia V IancuCorin Virgil Badiu
Apr 10, 2021·Frontiers in Medicine·Sule CanberkValdemar Máximo
Jul 18, 2021·Scientific Reports·Sarocha VivatvakinSaknan Bongsebandhu-Phubhakdi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Cancer Imaging

Imaging techniques, including CT and MR, have become essential to tumor detection, diagnosis, and monitoring. Here is the latest research on cancer imaging.